Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

BACKGROUND: The choice of drugs for treatment of advanced gastric cancer (GC) is empirical. The purpose of the current study was to benchmark ex vivo the sensitivity of GC tumor cells from patients to standard cytotoxic and some newly introduced targeted drugs (TDs), as a basis for drug selection in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hultman, Bo, Mahteme, Haile, Sundbom, Magnus, Ljungman, Martin, Larsson, Rolf, Nygren, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304126/
https://www.ncbi.nlm.nih.gov/pubmed/25528067
http://dx.doi.org/10.1186/s13046-014-0110-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304126/
https://www.ncbi.nlm.nih.gov/pubmed/25528067
http://dx.doi.org/10.1186/s13046-014-0110-9

Ejemplares similares